TrkA expression decreases the in vivo aggressiveness of C6 glioma cells

Cancer Research

Volumn 57, Issue 3, 1997, Pages 532-536

  Lachyankar, Mahesh B ^a   Ross, Alonzo H ^a   Scott Litofsky, N ^a   Condon, Peter J ^a   Quesenberry, Peter J ^a   Recht, Lawrence D ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NERVE GROWTH FACTOR RECEPTOR;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CELL DIFFERENTIATION; CELL INVASION; CELL SURVIVAL; CONTROLLED STUDY; GENE EXPRESSION; GLIOBLASTOMA; GLIOMA CELL; MALE; NEUROBLASTOMA; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; GLIOMA; MALE; NEOPLASM INVASIVENESS; PROTO-ONCOGENE PROTEINS; RATS; RATS, INBRED WKY; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, TRKA; RECEPTORS, NERVE GROWTH FACTOR; TUMOR CELLS, CULTURED;

EID: 0031056475     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Leibel, S. A., Sheline, G. E., Wara, W. M., Boldrey, E. B., and Nielsen, S. L. The role of radiation therapy in the treatment of astrocytomas. Cancer (Phila.), 35: 1551-1557, 1975.
2. Shaw, E. G., Daumas-Duport, C., Scheithauer, B. W., Gilbertson, D. T., O'Fallon, J. R., Earle, J., Laws, E. R., and Okazaki, H. Radiation therapy in the management of low-grade supratentorial astrocytomas. J. Neurosurg., 70: 853-861, 1989.
3. Krouwer, H. G. J., Davis, R. L., McDermott, M. W., Hoshino, T., and Prados, M. D. Gangliogliomas: a clinicopathologic study of 25 cases and review of the literature. J. Neuro-oncol., 17: 139-154, 1993.
4. Recht, L. D., and Bernstein, M. Low-grade gliomas. Neurol. Clin. North Am., 13: 847-859, 1995.
5. Zentner, J., Wolf, H. K., Ostertun, B., Hufnagel. A., Campos, M. G., Solymosi, L., and Schramm, J. Gangliogliomas: clinical, radiological, and histopaihological findings in 51 patients. J. Neurol. Neurosurg. Psychiatry, 57: 1497-1502, 1995.
6. Nakagawara, A., Arima-Nakagawara, M., Scavarda, N. J., Azar, C. G., Cantor, A. B., and Brodeur, G. M. Association between high levels of expression of the trk gene and favorable outcome in human neuroblastoma. N. Engl. J. Med., 328: 847-854, 1993.
7. Kogner, P., Barbany, G., Dominici, C., Castello, M. A., Raschella, G., and Persson, H. Coexpression of messenger RNA for trk protooncogene and low affinity nerve growth factor receptor in neuroblastoma with favorable prognosis. Cancer Res., 53: 2044-2050, 1993.
8. Segal, R. A., Goumnerova, L. C., Kwon, Y. K., Stiles, C. D., and Pomeroy, S. L. Expression of the neurotrophin receptor trkC is linked to a favorable outcome in medulloblastoma. Proc. Natl. Acad. Sci. USA, 91: 12867-12871, 1994.
9. Matsushima, H., and Bogenmann, E. Expression of trkA cDNA in neuroblastomas mediates differentiation in vitro and in vivo. Mol. Cell. Biol., 13: 7447-7456, 1993.
10. Lavenius, E., Gestblom, C., Johansson, I., Nanberg, E., and Pahlman, S. Transfection of Trk-A into human neuroblastoma cells restores their ability to differentiate in response to nerve growth factor. Cell Growth & Differ., 6: 727-736, 1995.
11. Poluha, W., Poluha, D. K., and Ross, A. H. TrkA neurogenic receptor regulates differentiation of neuroblastoma cells. Oncogene. 10: 185-189, 1995.
12. Hamel, W., Westphal, M., Szonyi, E., Escandon, E., and Nikolics, K. Neurotrophin gene expression by cell lines derived from human gliomas. J. Neurosci. Res., 34: 147-157, 1993.
13. Colangelo, A. M., Fink, D. W., Rabin, S. J., and Mocchetti, I. Induction of nerve growth factor responsiveness in C6-2B glioma cells by expression of trkA protooncogene. Glia, 12: 117-127, 1994.
14. Oelmann, E., Sreter, L., Schuller, I., Serve, H., Koenigsmann, M., Wiedenmann, B., Oberberg, D., Reufi, B., Thiel, E., and Berdel, W. E. NGF stimulates clonal growth of human lung cancer cell lines and a human glioblastoma cell line expression high-affinity nerve growth factor binding sites involving tyrosine kinase signaling. Cancer Res., 55: 2212-2219, 1995.
15. Bernstein, J. J., Goldberg, W. J., Laws, E. R., Conger, D., Morreale, V., and Wood, L. R. C6 glioma cell invasion and migration of rat brain after neural homografting: ultrastructure. Neurosurgery, 26: 622-628, 1990.
16. Bernstein, J. J., Laws, E. R., Levine, K. V., Wood, L. R., Tadvalkar, G., and Goldberg, W. J. C6 glioma-astrocytoma cell and fetal astrocyte migration into artificial basement membrane: a permissive substrate for neural tumors but not fetal astrocytes. Neurosurgery, 28: 652-658, 1991.
17. Chicoine, M. R., and Silbergeld, D. L. Invading C6 glioma cells maintaining tumorigenicity. J. Neurosurg., 83: 665-671, 1995.
18. Wyatt, S., and Davies, A. M. Regulation of expression of mRNAs encoding the nerve growth factor receptors p75 and trkA. Development, 119: 635-647, 1993.
19. Sheffield, J. B., Graff, D., and Li, H. P. A solid-phase method for the quantitation of protein in the presence of sodium dodecyl sulfate and other interfering substances. Anal. Biochem., 166: 49-54, 1987.
20. Ross, A. H., Daou, M-C., McKinnon, C. A., Condon, P. J., Lachyankar, M. B., Stephens, R. M., Kaplan, D. R., and Wolf, D. E. A complex of the gp75 and TrkA nerve growth factor receptors demonstrated by copatching. J. Cell Biol., 132: 945-953, 1996.
21. Plattner, R., Anderson, M. J., Sato, K. Y., Fasching, C. L., Ker, C. I., and Stanbridge, E. J. Loss of oncogenic ras expression does not correlate with loss of tumorigenicity in human cells. Proc. Natl. Acad. Sci. USA, 93: 6665-6670, 1996.
22. Frederiksen, K., and McKay, R. Proliferation and differentiation of rat neuroepithelial precursor cells in vivo. J. Neurosci., 8: 1144-1151, 1988.
23. Reynolds, C. P., and Perez-Polo, J. R. Induction of neurite outgrowth in the IMR-32 human neuroblastoma cell line by nerve growth factors. J. Neurosci. Res., 6: 319-325, 1981.
24. Donovan, M. J., Hempstead, B. L., Horvath, C., Chao, M. V., and Schofield, D. Immunohistochemical localization of Trk receptor protein in pediatric small round blue cell tumors. Am. J. Pathol., 143: 1560-1567, 1993.
25. de Ridder, L., and Calliauw, L. Invasiveness of primary and secondary brain tumors in vitro correlated with clinical results. Neurosurgery, 31: 1043-1048, 1992.
26. Nazzaro, J. M., and Neuwelt, E. A. The role of surgery in the management of supratentorial intermediate and high-grade astrocytomas in adults. J. Neurosurg., 73: 331-344, 1990.